Unraveling the Physiology of (pro)renin Receptor in the Distal Nephron
Tianxin Yang
DOI: https://doi.org/10.1161/hypertensionaha.116.08318
IF: 9.8968
2017-01-01
Hypertension
Abstract:HomeHypertensionVol. 69, No. 4Unraveling the Physiology of (Pro)Renin Receptor in the Distal Nephron Free AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUBUnraveling the Physiology of (Pro)Renin Receptor in the Distal Nephron Tianxin Yang Tianxin YangTianxin Yang From the Department of Internal Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City; and Institute of Hypertension, Sun Yat-sen University School of Medicine, Guangzhou, China. Search for more papers by this author Originally published27 Feb 2017https://doi.org/10.1161/HYPERTENSIONAHA.116.08318Hypertension. 2017;69:564–574Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: January 1, 2017: Previous Version 1 The classic renin–angiotensin system (RAS) is a well-defined endocrine system consisting of liver production of angiotensinogen, which is converted to angiotensin I by renin followed by a second cleavage to angiotensin II (AngII) by angiotensin-converting enzyme located on the surface of lung endothelium.1,2 AngII is the major effector hormone of the RAS, playing a key role in the maintenance of extracellular volume, blood pressure, renal hemodynamics, and tubular sodium transport, as well as in the pathogenesis of cardiovascular and renal diseases.3–5 AngII acts on 2 types of membrane receptors, AngII type 1 receptor and type 2 receptor. The RAS interventions targeting AngII type 1 receptor and angiotensin-converting enzyme are widely used for management of hypertension, renal disease, and cardiovascular disease. During the past several decades, the RAS has evolved into a highly complex system as highlighted by the discovery of angiotensin-converting enzyme 2/Ang 1 to 7/Mas pathway and the local RAS found in several tissues, such as the kidney, the heart, and the brain.1,6,7 The RAS activity is largely controlled by renin-mediated conversion of angiotensinogen to Ang I, a rate-limiting step in the RAS. Renin is a protease produced by juxtaglomerular cells of the afferent arteriole as well as collecting duct (CD) principal cells,8 mast cells,9 adipocytes,10 etc. Prorenin, a precursor of renin, contains a prosegment covering the catalytic domain and undergoes proteolytic cleavage to generate the mature renin. Plasma prorenin levels are elevated in diabetic patients and predict microvascular complications, whereas plasma renin is normal or low.11 Animal data suggests that excess prorenin compared with active renin in diabetes mellitus originates from the CD rather than from the juxtaglomerular apparatus.12 High prorenin state is also seen in normal pregnancy.13,14In 2002, Nguyen et al15 cloned a novel receptor for prorenin and renin, termed (pro)renin receptor (PRR), and assigned a renin-regulatory function to this receptor. Renin bound to PRR exhibits a 3- to 5-fold increased renin activity.15 Furthermore, when PRR binds prorenin, the later undergoes conformational changes to unfold the inhibitory prosegment of prorenin, leading to nonproteolytic activation.15 A soluble form of PRR (sPRR) is generated by intracellular cleavage by furin and secreted in plasma.16 On the basis of the structure, PRR belongs to type I transmembrane receptor family, consisting of a large N-terminal extracellular domain, a single transmembrane protein, and a short cytoplasmic domain.15,17 Amino acid sequence analysis reveals that the intracellular domain of PRR is highly conserved among all species, whereas the extracellular domain shares high homology only in mammals. The conservation scores (identity /AA) are 6.8 for the intracellular domain (M8.9) and 3.8 for the extracellular domain (sPRR) among all species, and 8.7 for the intracellular domain and 8.9 for sPRR in mammals (Figure 1). This result is compatible with the concept that sPRR may serve an important function in mammals, whereas M8.9 may participate in fundamental survival functions across all species.Download figureDownload PowerPointFigure 1. Distinct conservations of different domains of (pro)renin receptor (PRR). The protein sequence alignment was generated by the Clustal X 2.0 multiple sequence alignment program using default parameters. The PRR protein sequences were from GenBank accession numbers NP_005756.2 (human), NP_001126837.1 (Pongo abelii), AAH79339.1 (rat), NP_081715.1 (mouse), NP_001080880.1 (Xenopuslaevis), NP_998188.2 (Zebrafish), NP_510360.1 (Caenorhabditis elegans), and NP_649876.1 (Drosophila melanogaster). A, Alignment of amino acid sequence of PRR. The score depicts conservation between different species. The scores on the bottom 2 rows depict degrees of conservation across all species and the mammals only. The transmembrane domain (TM), the intracellular domain (ICD), and furin-mediated cleavage site are highlighted. B, The summary of the conservation scores.Within the kidney, PRR is expressed in multiple cell types and is most abundantly detected in the intercalated cells of the CD,18–20 a site for fine-tuning urinary excretion of water and electrolytes; the expression of PRR in the CD is stimulated by chronic AngII infusion21 or Na+ depletion.22,23 During the past decade, understanding the physiological function of PRR has been hindered by the lethal phenotype of complete or conditional deletion of PRR and also the lack of an effective PRR inhibitor with the controversial antagonistic effect of handle region peptide on the PRR.24–26 In recent years, the availability of various strains of viable renal PRR knockout (KO) models along with the newly developed PRR decoy inhibitor PRO20 has greatly facilitated the process in unraveling the physiological function of renal PRR. The existing in vivo data suggests that PRO20 acts via inhibition of the RAS during both AngII infusion and deoxycorticosterone acetate–salt hypertension,27,28 although in vitro data shows the RAS-independent effect of this inhibitor on epithelial Na+ channel (ENaC) activity.29 The goal of this review is to highlight recent advances in identifying the roles of PRR in the nephron, particularly in the CD, for regulation of Na+ and water balance and blood pressure.PRR Regulation of Na+ HomeostasisA series of recent studies from our group and others have identified the prorenin/PRR pathway as a potential regulator of ENaC in the CD. Because prorenin/renin and PRR are coexpressed in the CD, we hypothesized that their interactions in an autocrine or paracrine fashion may affect ENaC activity. To address this possibility, we performed electrophysiological studies using mpkCCD cell line grown on Transwells. Using this system, we made an initial observation that prorenin treatment in the nanomolar range induced a rapid and transient increase in ENaC-mediated Na+ transport (Figure 2) through Nox4-derived H2O2.29 Interestingly, renin treatment was largely ineffective. In agreement of this observation, multiple studies suggest that prorenin has higher affinity to PRR than renin.30,31 The dependence of the Na+ stimulatory effect of prorenin on PRR was validated by using a PRR decoy inhibitor PRO20.29 This effect was independent of canonical RAS because AT1 receptor inhibition with losartan was ineffective (Figure 2). These results suggest that prorenin via PRR induces Nox4-derived reactive oxygen species, resulting in a direct activation of ENaC. In agreement with this finding, Ramkumar et al32 observed a similar stimulatory effect of prorenin on ENaC activity in isolated split-open CD. Moreover, the prorenin effect was similarly unaffected by AT1 blockade.32 Besides the ENaC regulation at activity level, PRR also upregulates α-ENaC mRNA expression in mIMCD3 cells exposed to low-salt media or AngII through serine/threonine-protein kinase-1 and phosphorylated Nedd4-2 (also known as Nedd4L [neural precursor cell-expressed developmentally downregulated gene 4-like]).33 Together, the in vitro results suggest that PRR can modulate ENaC expression and activity through distinct mechanisms.Download figureDownload PowerPointFigure 2. Effect of prorenin/(pro)renin receptor (PRR) on epithelial Na+ channel (ENaC) activity in cultured collecting duct (CD) cells. Confluent mpkCCD cells grown on Transwells were pretreated for 30 min with PRO20 (1.5 µmol/L) or losartan (Los; 1.0 µmol/L) and then treated with prorenin (10 nmol/L). Ieq was monitored for a 15-min period by using an epithelial volt-ohmmeter. In a separate experiment, the time point of peak stimulation of Na+ transport at 1 min was chosen for measuring amiloride-sensitive Ieq, an index of ENaC activity. A, Time course of Ieq changes in control, prorenin, and prorenin+PRO20 groups. B, Corresponding amiloride-sensitive Ieq for experiments in (A). C, Time course of Ieq changes in control, prorenin, and prorenin+losartan groups. D, Corresponding amiloride-sensitive Ieq for experiments in (C). *P<0.05 vs basal in the same group; #P<0.05 vs prorenin. n=6 to 12 per group. Data are means±SE. Adapted from Lu et al.29 Copyright © 2016, American Physiological Society.Besides the above-mentioned in vitro data, strong in vivo data from 3 independent studies all support an important role of PRR in ENaC regulation under basal and pathophysiological conditions.29,32,33 To our surprise, PRR regulation of ENaC seems to occur only in the renal medulla but not in the cortex. In this regard, we found that the renal inner medullary α-ENaC under basal condition or after AngII infusion was reduced in CD PRR KO mice.34 In contrast, renal cortical α-ENaC expression was unaffected by AngII or CD PRR KO. Moreover, the other ENaC subunits (β and γ) remain unchanged. In agreement with our results, Quadri et al33 showed that in vivo delivery of shRNA against PRR to the kidney of Sprague-Dawley rats selectively reduced α-ENaC expression in the renal medulla but not in the cortex despite the gene knockdown in the whole kidney. These results suggest that PRR may primarily target renal medullary (or inner medullary) ENaC to regulate Na+ balance and BP.As compared with the overwhelming information about Na+ transport process in the early part of the CD,35–38 little attention has been paid to the terminal part of the CD, for example, the inner medullary collecting duct (IMCD). Part of the reason is that the IMCD in rabbits or rats is highly branched or difficult to dissect because of tightly adherent tissues and therefore is not easily accessible to microperfusion as for the cortical CD. The literature concerning net Na+ transport in the IMCD is controversial. It has been difficult to demonstrate net Na+ reabsorption in isolated perfused IMCD by measurement of Na+ concentrations in the perfusate.39 However, other studies reported robust Na+ reabsorption in this nephron segment.40,41 Furthermore, the apical membrane conductance in the IMCD because of passive movement of Na+ is detected and attributed to amiloride-sensitive conductive pathway.42 In addition, Na+ reabsorption in the IMCD has been demonstrated by using micropuncture techniques. The IMCD is accessible to micropuncture through a retrograde placement of thin pipettes from the tip of the IMCD. Early micropuncture studies using this technique have demonstrated active net Na+ reabsorption in the IMCD.43,44 More importantly, Na+ reabsorption in the IMCD fluctuates in response to altered plasma volume so that it is increased during hypovolemia but suppressed during volume expansion44–47 despite a conflicting report.48 Overall, these results suggest a potential role of Na+ transport in the IMCD in the control of Na+ excretion during alteration of plasma volume. Unfortunately, this area has almost remained uninvestigated during the past decade. It is anticipated that the demonstration of PRR as a regulator of renal medullary ENaC will provide an impetus for re-evaluation of importance of Na+ transport in the IMCD.As discussed above, PRR regulation of renal medullary α-ENaC contributes to pathogenesis of AngII-induced hypertension.34 In addition, dysregulation of renal medullary ENaC has been implicated in the development of salt-sensitive hypertension in Dahl salt–sensitive rats.49 Based on the conductive permeability to Na+ and the rate of Na+ transport, the IMCD cells from Dahl salt-sensitive rats transport twice as much Na+ as the cells from Dahl salt–resistant rats.50,51 Consistent with this finding, the mRNA of β- and γ-ENaC and the protein abundance of all 3 ENaC subunits are increased in the renal medulla of Dahl salt-sensitive rats under basal condition and after high salt intake as compared with Dahl salt-resistant rats.49 Additionally, aberrant activation of intrarenal RAS has been suggested to play a role in the Dahl salt-sensitive model, which is traditionally considered as a low renin hypertension model. Despite the similar suppression of plasma angiotensinogen in both strains, high salt enhances renal and urinary levels of angiotensinogen in Dahl salt-sensitive but not in Dahl salt-resistant rats.52 Future studies need to address the precise location of the intrarenal RAS activation and possible involvement of PRR in salt-sensitive hypertension in the Dahl salt-sensitive model.PRR Regulation of Water HomeostasisMost mammals can produce highly concentrated urine when water consumption is reduced so that a constant plasma osmolality can be maintained. Such urine-concentrating capability resides in the renal medulla and is chiefly determined by arginine vasopressin (AVP).53,54 The antidiuretic action of AVP is mediated by enhancement of water permeability of the CD and the generation of osmotic gradient because of increased NaCl reabsorption in the thick acceding limb (TAL).54,55 In the CD, AVP via arginine vasopressin receptor 2 (V2R) activates cyclic AMP/protein kinase A pathway that induces aquaporin-2 (AQP2) trafficking to the apical membrane and expression leading to increased water permeability.53 We discovered that AVP-stimulated AQP2 expression depends on prorenin activation of PRR.56 In primary rat IMCD cells on Transwells, AVP induced a marked increase in AQP2 protein expression. To address the involvement of PRR, we used 3 independent approaches to inhibit PRR: a pharmacological inhibitor, a small and interfering RNA, and a neutralizing PRR antibody. Inhibition of PRR with either one of these approaches was highly effective to suppress AQP2 upregulation by AVP. Furthermore, activation of PRR with prorenin but not renin induced a marked increase in AQP2 expression (Figure 3). AVP also stimulated release of prorenin and sPRR in primary rat IMCD cells.56 In M-1 CD cell line, a similar enhancement of renin mRNA, prorenin, and renin is observed after desmopressin (ddAVP) treatment.57 Together, the in vitro data demonstrates a potential role of PRR in mediating AVP-induced AQP2 expression in the CD cells. However, whether PRR regulates AVP-induced AQP2 trafficking remains uninvestigated.Download figureDownload PowerPointFigure 3. The direct role of prorenin/(pro)renin receptor (PRR) in regulation of aquaporin-2 (AQP2) expression in the collecting duct (CD) cells. Primary rat inner medullary collecting duct cells were pretreated with PRO20 or anti-PRR-N antibody or pretransfected with PRR small and interfering RNA (siRNA) and then treated for 24 h with 10 nmol/L prorenin. AQP2 protein expression was determined by immunoblotting and normalized by β-actin. A, Effect of prorenin alone or in combination with PRO20 on AQP2 expression (n=6 per group). B, Effect of prorenin alone or in combination with anti-PRR-N antibody on AQP2 expression (n=6 per group). C, Effect of prorenin alone or in combination with PRR knockdown on AQP2 expression (n=6 per group). Adapted from Wang et al56 with permission of the publisher. Copyright © 2016, American Society of Nephrology. Authorization for this adaptation has been obtained both from the owner of the copyright in the original work and from the owner of copyright in the translation or adaptation.In agreement with the in vitro data as discussed above, compelling in vivo data are also available to support antidiuretic action of renal PRR. First, renal full-length PRR protein abundance is consistently elevated in rats after 48-hour or 72-hour water deprivation (WD).56,58 Interestingly, this maneuver increases urinary sPRR excretion56 but decreases plasma sPRR.55 This result may suggest differences in the origin of urinary and plasma sPRR. Second, pharmacological inhibition of intrarenal PRR results in impaired urine-concentrating capability.56 In this regard, PRO20 is administered via an infusion catheter chronically implanted in the kidney of nephrectomized rats followed by 48-hour WD. Intrarenal PRO20 infusion partially attenuates the reduction of urine volume and the increase of urine osmolality and the expression of AQP2 in the WD rats. Finally, conditional deletion of PRR56 in the CD and the whole nephron59,60 causes a common polyuria phenotype. CD PRR KO mice generated by using AQP2-Cre are not associated with renal developmental abnormality seen in the null model produced by using Hoxb7-Cre.61 The whole nephron PRR deletion is generated by using an inducible way wherein PRR ablation occurs in adulthood so that the developmental stage is bypassed. All of these KO models have increased urine volume and decreased urine osmolality under basal condition and exhibit impaired ability to concentrate urine after WD. Evidence is available to suggest impairment of AVP signaling in these models. For example, renal AQP2 expression is consistently downregulated in these models, and AVP sensitivity is also blunted in the nephron PRR KO mice. Besides AQP2, renal expression of Na/K/2Cl cotransporter, another target of AVP in the TAL,55 is also suppressed in the null mice. These results suggest that PRR is indispensable for AVP signaling in both the CD and the TAL. However, it is important to note that interpretation of the phenotype of the nephron PRR KO model is complicated by renal structural abnormalities because of accumulation of autophagosome particularly in the TAL. This result raises a possibility that the downregulation of transporter proteins such as Na/K/2Cl cotransporter in this model may be secondary to an autophagic defect in the renal epithelial cells.EP4 Regulation of PRRFurther evidence suggests that prostaglandin EP4 receptors are required for enhancement of PRR and hence AQP2 after AVP treatment. PGE2 is one of the major cyclooxygenase-derived metabolites of arachidonic acid produced in the kidney, particularly the IMCD.62,63 PGE2 acts on 4 distinct G protein–coupled receptors, designated EP1–4, to induce a wide spectrum of biological functions.64 PGE2 exerts a prominent, yet complex, role in the regulation of water homeostasis through distinct EP receptors. In particular, PGE2 and sulprostone, an EP1/3 agonist, blunt AVP-induced AQP2 trafficking and urine concentration,65–68 whereas EP2 and EP4 agonists induces AQP2 trafficking to the apical membrane and alleviate the symptoms of nephrogenic diabetes insipidus (NDI) in rodents.69 A nonbiased gene expression analysis of G protein–coupled receptor in mouse IMCD cells identified the prostaglandin EP4 subtype as the highly expressed G protein–coupled receptor in addition to the V2R.69 In microdissected nephron segments, EP4 mRNA was abundantly detected in the cortical CD,70 where PGE2 stimulated cyclic AMP production.71 After 24-hour WD, EP4 protein expression is remarkably upregulated contrasting to unchanged expression of the other 3 EP subtypes,72 indicating a unique role of EP4 receptors in regulation of water homeostasis. This notion has been confirmed by generation of nephron-specific (Ksp-EP4−/−) and CD-specific (AQP2-EP4−/−) deletion of EP4, both of which impair urine-concentrating capability.72 An earlier study from our group showed that EP4 acting downstream of cyclooxygenase-2 mediates upregulation of renal medullary PRR and the intrarenal RAS during AngII-induced hypertension.73,74 Therefore, we proposed a hypothesis that PGE2/EP4 pathway may mediate the antidiuretic action of AVP via targeting PRR and the intrarenal RAS. We found that in primary rat IMCD cells, activation of EP4 receptors was able to stimulate AQP2 expression, and conversely, inhibition of this receptor subtype effectively attenuates AVP-induced AQP2 expression.56 These results suggest the EP4 receptor as a mediator of AVP-induced AQP2 expression. Because EP4 agonist stimulated PRR expression74 and EP4-induced AQP2 expression was blunted by inhibition of PRR, the EP4 receptor should act downstream of AVP and upstream of PRR in regulation of AQP2 expression.Biological Function of sPRRPRR contains a protease cleavage site at the N-terminal domain near the transmembrane domain.15 sPRR was originally shown to be generated by intracellular cleavage by furin and detected in the conditioned medium of cultured cells.16 This conclusion was based on the observations that LoVo colon carcinoma cells deficient in furin did not produce sPRR despite the expression of full-length PRR and that overexpression of α1-antitrypsin Portland variant, an inhibitor of furin, completely suppressed sPRR production in Chinese hamster ovary cells.16 However, the role of furin as the cleaving enzyme was not confirmed by another study.75 In the later study, ADAM19, but not furin, is shown to be responsible for the cleavage process.75 Moreover, in cultured vascular smooth muscle cells, PRR is mainly localized to the endoplasmic reticulum and the Golgi and shed by ADAM19 in the Golgi, leading to the secretion of sPRR to the extracellular space where it enhances renin activity of prorenin.75 Thus, the relative importance of furin versus ADAM19 in this cleavage event remains elusive.A large number of clinical studies suggest importance of circulating sPRR. sPRR can be measured by ELISA,76 which offers a simple tool for assessment of sPRR in the body fluid. By ELISA, serum levels of sPRR are increased during pregnancy77,78 and in patients with heart failure,79 gestational diabetes mellitus,80 obstructive sleep apnea syndrome,81 and primary epithelial ovarian cancer.82 In 374 patients with chronic kidney disease caused by hypertension and type 2 diabetes mellitus, serum sPRR is positively associated with serum creatinine, blood urea nitrogen, and proteinuria and inversely with estimated glomerular filtration rate.83 It is puzzling, however, that in this study serum sPRR levels were lower in patients with primary hypertension or diabetes mellitus than in those without these conditions.83 In 25 patients who underwent uninephrectomy, plasma sPRR further correlated with renal tubulointerstitial fibrosis.84 Despite the lack of correlation of plasma sPRR with circulating renin, prorenin, and aldosterone in healthy subjects,85 sPRR correlates positively with urinary angiotensinogen in patients with essential hypertension.86 Urinary angiotensinogen is widely considered as an index of intrarenal RAS87 despite some evidence for its hepatic origin.88 Overall, most of the previous studies favor plasma sPRR as a biomarker of certain diseases likely because of its association with the intrarenal RAS.A clue suggesting a biological function of renal PRR came from our immunostaining studies comparing antibodies against the different PRR domains. A commercial antibody against the C terminus of PRR (anti-PRR-C antibody)18,20 reproducibly labeled intercalated cells. However, to our surprise, an antibody against the N terminus of PRR (sPRR) only stained the apical membrane of principal cells. The anatomic evidence suggested an intriguing possibility that sPRR might be secreted from intercalated cells and secreted to the luminal side and then bind an as yet unknown protein on the apical membrane of principal cells, revealing a paracrine loop linking the 2 cell types in the CD; this paracrine mechanism may play a role in regulation of Na+ and water transport in the principal cells of the CD. To test this hypothesis, we generated a histidine-tagged recombinant sPRR, termed as sPRR-His, and examined its effect on AQP2 expression in primary IMCD cells. sPRR-His at the nanomolar range remarkably induced AQP2 mRNA and protein expression (Figure 4).89 The parallel increase in AQP2 promoter activity (Figure 4) suggested that the transcriptional mechanism may account for the upregulation of AQP2 expression by sPRR-His.89 We used STRING to predict proteins that interact with sPRR. This led to the discovery of frizzled-8 that interacted with sPRR to activate Wnt/β-catenin pathway and thus enhancement of AQP2 gene transcription.89 However, this mechanism does not seem to contribute to AQP2 redistribution after an acute AVP treatment.89 Because AVP stimulated sPRR release, we speculate that the sPRR/β-catenin/AQP2 pathway may primarily mediate the upregulation of AQP2 transcription during chronic AVP treatment. Although previous studies extensively focus on the detailed signaling mechanism of AQP2 trafficking between intracellular vesicles and apical plasma membrane, which occurs within minutes of AVP treatment,53,54,90,91 little is known about the mechanism of transcriptional regulation of AQP2 gene under chronic condition. Our results uncovered a novel role of sPRR in transcriptional regulation of AQP2 expression.Download figureDownload PowerPointFigure 4. Characterization of function of soluble form of (pro)renin receptor (sPRR). A recombinant PRR, termed sPRR-His (histidine-tagged recombinant sPRR), was expressed in a mammalian expressing system as a fusion protein that contained sPRR, a histidine tag in the C terminus, and a secretion signal peptide in the N terminus. A, sPRR-His was purified from the medium as a single 29.6 kDa band in 12% SDS PAGE. E1 to 4 denotes sequential fractions from the elution. B and C, Primary rat inner medullary collecting duct cells grown in Transwells were exposed to 10 nmol/L sPRR-His for 24 h, and aquaporin-2 (AQP2) expression was analyzed by qRT-quantitative real-time PCR and immunoblotting (n=5 per group). D, In a separate experiment, the cultured CD cells were transfected with an AQP2–luciferase construct and allowed to grow to confluence and then treated with vehicle or 10 nmol/L sPRR-His for 24 h, and the luciferase activity was assayed (n=5 per group). E, STRING is a template-based algorithm for protein–protein structure prediction. We used STRING to identify proteins that interact with sPRR. This analysis revealed 10 hits: CTSG (cathepsin G), ACE2 (angiotensin 1-converting enzyme 2), CMA1 (chymase 1), MME (membrane metalloendopeptidase), ACE (angiotensin 1-converting enzyme 1), CTSZ (cathepsin Z), ENPEP (glutamyl aminopeptidase), FZD8 (frizzled family receptor 8), WNT3A (wingless-type MMTV intergration 3A), and LRP6 (low-density lipoprotein receptor–related protein 6). Adapted from Lu et al.89 Copyright © 2016, National Academy of Sciences.The Wnt/β-catenin pathway is a multifunctional network critically involved in embryogenesis.92 Dephosphorylated β-catenin translocates to the nucleus where it recruits several transcription factors, such as lymphoid enhancer–binding factor 1/T cell–specific transcription factor.93 In low vertebrates including zebrafish and Xenopus, PRR functions as a key component of the membrane receptor complex in Wnt signaling to control embryogenesis.94 In addition, the Wnt/β-catenin pathway is also involved in physiological and pathophysiological processes. Aberrant activation of this pathway contributes to pathogenesis of chronic kidney disease.95–97 Our recent work demonstrates that the coupling of PRR with β-catenin signaling is operative in the setting of physiological regulation of water transport in the distal nephron.89 In support of this observation, Jung et al98 reported that tankyrase-mediated β-catenin pathway mediated AVP-induced AQP2 expression in mpkCCDc14 cells.The mechanism of how AVP regulates sPRR production, particularly the involvement of V1R versus V2R and intercalated cells versus principal cells, largely remains elusive. It has been shown that within the CD, V1R is mainly expressed in the intercalated cells regulating urine acidification.99 Given colocalization of V1R and PRR to the intercalated cells, it seems possible that V1R may mediate AVP-induced sPRR production. Another possibility also exists that V2R in principal cells may affect intercalated cell sPRR production through an intermediate mediator such as prostaglandins. Indeed, we found involvement of the prostaglandin EP4 receptor in mediating AVP-induced activation of PRR.56The in vitro capability of sPRR-His to regulate AQP2 expression as discussed above predicts an antidiuretic action of sPRR. This prediction has been confirmed by in vivo studies using 2 types of diabetes insipidus modes induced by inhibition of V2R and liver X receptor.89 Administration of sPRR-His via an intravenous route effectively attenuated polydipsia and polyuria and partially restored urine osmolality in both models.89 These results demonstrate therapeutic potential of sPRR-His for treatment of diabetes insipidus, particularly NDI. Central diabetes insipidus is caused by deficiency of AVP and thus can be treated with supplementing the missing hormone.100,101 NDI results from the insensitivity of the kidney to AVP usually because of genetic abnormalities with 90% of families having a mutation in V2R102,103 or with AQP2 mutations accounting for rest of the other families.104 Patients with NDI usually develop severe polyuria and polydipsia. It is particularly astonishing that children with congenital NDI can produce 20 L of urine daily and must drink a comparable amount of water to avoid dehydration.101 Infants with this disease may fail to thrive. To date, a specific therapy for